Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Myasthenia Gravis × remibrutinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

efgartigimod alfa 6 fludarabine 4 Cyclophosphamide 4 zilucoplan 2 telitacicept 2 rozanolixizumab 2 ravulizumab 2 remibrutinib 1 iptacopan 1 inebilizumab 1 bu-zhong-yi-qi-tang 1 Walk Test 1 Tacrolimus 1 Steroids 1 Pyridostigmine Bromide 1 Prednisone 1 Mycophenolic Acid 1 Data Collection 1 Cognitive Behavioral Therapy 1 Cladribine 1 Biomarkers 1 Azathioprine 1 Alleles 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06744920 2026-02-20

RELIEVE

Novartis

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡